APA (7th ed.) Citation

C, I., M, S., & N, M. (2018). Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor. International journal of oncology, 53(4), 1681. https://doi.org/10.3892/ijo.2018.4513

Chicago Style (17th ed.) Citation

C, Ishikawa, Senba M, and Mori N. "Anti-adult T‑cell Leukemia/lymphoma Activity of Cerdulatinib, a Dual SYK/JAK Kinase Inhibitor." International Journal of Oncology 53, no. 4 (2018): 1681. https://doi.org/10.3892/ijo.2018.4513.

MLA (9th ed.) Citation

C, Ishikawa, et al. "Anti-adult T‑cell Leukemia/lymphoma Activity of Cerdulatinib, a Dual SYK/JAK Kinase Inhibitor." International Journal of Oncology, vol. 53, no. 4, 2018, p. 1681, https://doi.org/10.3892/ijo.2018.4513.